logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rumei Chen

Biotechnology Research Institute
H指数:22
被引数:1,854

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC (vol 4, pg 860, 2023)
NATURE CANCER
IF28.5
2024-01-050
OA
Zhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
NATURE CANCER
IF28.5
2023-06-1512
OA
Zhou, Caicun; Wang, Ziping; Sun, Meili; Cao, Lejie; Ma, Zhiyong; Wu, Rong; Yu, Yan; Yao, Wenxiu; Sun, Si; Chen, Jianhua; Zhuang, Wu; Cui, Jiuwei; Chen, Xueqin; Lu, You; Shen, Hong; Hu, Chunhong; Liu, Jiwei; Liu, Yunpeng; Wang, Mengzhao; Li, Xingya; Sun, Ping; Shu, Yongqian; Zhou, Jianying; Li, Jingzhang; Gu, Kangsheng; Wang, Changli; Zhao, Hui; Zhang, Yiping; Liu, Chunling; Wang, Jingru; Chen, Rumei; Qin, Mengmeng; Wang, Hao; Yang, Jason

研究方向

暂未获取到该数据
周
周晓今
H 指数:23论文数:68被引数:1,655
柳
柳小庆
H 指数:37论文数:326被引数:4,887
W
Wenzhu Yang
H 指数:16论文数:55被引数:953
Y
Yunliu Fan
H 指数:39论文数:218被引数:5,053
李
李素贞
H 指数:0论文数:2被引数:0
张
张春翌
H 指数:36论文数:188被引数:4,235
S
Shuai Ma
H 指数:7论文数:14被引数:154
Y
Ye Li
H 指数:27论文数:78被引数:1,678
李
李素贞
H 指数:34论文数:280被引数:4,478
S
Suzhen Li
H 指数:3论文数:6被引数:51